Eye Infections Therapeutics Market by Type and Geography - Global Forecast and Analysis 2019-2023

Global Eye Infections Therapeutics Market: About this market

Technavio’s eye infections therapeutics market analysis considers sales from conjunctivitis, keratitis, blepharitis, and other eye infections types. Our analysis also considers the sales of eye infections therapeutics in Asia, Europe, North America, and ROW. In 2018, the conjunctivitis segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the growing awareness about eye infections will play a significant role in the conjunctivitis segment to maintain its market position. Also, our global eye infections therapeutics market report looks at factors such as the rising geriatric population, high prevalence, and incidence of eye infections, and growing healthcare expenditure. However, patent expiry of blockbuster drugs, side effects associated with antibiotics, and stringent regulatory guidelines may hamper the growth of the eye infections therapeutics industry over the forecast period.

Global Eye Infections Therapeutics Market: Overview

Rising geriatric population

The geriatric population is more prone to ophthalmic problems because people are more vulnerable to eye infections as they age. Although eye infections account for a considerable proportion of these ophthalmic problems, there is a little clinical information in studies on infections, such as conjunctivitis and keratitis, among the elderly. Eye infection patients aged over 60 years generally need special medical attention as the condition can become more severe at that age. These factors will lead to the expansion of the global eye infections therapeutics market at a CAGR of almost 3% during the forecast period.

Growing adoption of generics

The consumption of generic drugs is gaining prominence in the market as the regulatory approval of these drugs is equally stringent as that for branded drugs. Generic drugs do not undergo clinical trials on animals and humans. This has significantly reduced the cost of generic drugs. Many patients and doctors are increasing their preference for generic drugs. In addition, they are identical to branded drugs in terms of intended use, route of administration, dosage, quality, strength, and price. They also contain similar benefits and active ingredients as their branded counterparts. These factors are encouraging the adoption of generic drugs for eye infections which will have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global eye infections therapeutics market during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of several major players, the global eye infections therapeutics market is highly fragmented. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading eye infections therapeutics manufacturers, that include Akorn Inc., Allergan Plc, Bausch Health Companies Inc., Bayer AG, Daiichi Sankyo Co. Ltd., GlaxoSmithKline Plc, Novartis AG, Pfizer Inc., Sanofi, and Santen Pharmaceutical Co. Ltd.

Also, the eye infections therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.


  • Executive summary
  • Scope of the report
    • Preface
      • Table Product overview
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global pharmaceuticals market
      • Table Segments of global pharmaceuticals market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by type
    • Table Type - Market share 2018-2023 (%)
    • Comparison by type
      • Table Comparison by type
    • Conjunctivitis - Market size and forecast 2018-2023
      • Table Conjunctivitis - Market size and forecast 2018-2023 ($ millions)
      • Table Conjunctivitis - Year-over-year growth 2019-2023 (%)
    • Keratitis - Market size and forecast 2018-2023
      • Table Keratitis - Market size and forecast 2018-2023 ($ millions)
      • Table Keratitis - Year-over-year growth 2019-2023 (%)
    • Blepharitis - Market size and forecast 2018-2023
      • Table Blepharitis - Market size and forecast 2018-2023 ($ millions)
      • Table Blepharitis - Year-over-year growth 2019-2023 (%)
    • Other eye infections - Market size and forecast 2018-2023
      • Table Other eye infections - Market size and forecast 2018-2023 ($ millions)
      • Table Other eye infections - Year-over-year growth 2019-2023 (%)
    • Market opportunity by type
      • Table Market opportunity by type
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2018-2023
      • Table North America - Market size and forecast 2018-2023 ($ millions)
      • Table North America - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in North America
    • Europe - Market size and forecast 2018-2023
      • Table Europe - Market size and forecast 2018-2023 ($ millions)
      • Table Europe - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Europe
    • Asia - Market size and forecast 2018-2023
      • Table Asia - Market size and forecast 2018-2023 ($ millions)
      • Table Asia - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Asia
    • ROW - Market size and forecast 2018-2023
      • Table ROW - Market size and forecast 2018-2023 ($ millions)
      • Table ROW - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in ROW
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Impact of drivers and challenges
  • Market trends
    • Rising number of government initiatives
    • Growing adoption of generics
    • Saturation in the pipeline landscape
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Akorn Inc.
      • Table Akorn Inc. - Vendor overview
      • Table Akorn Inc. - Business segments
      • Table Akorn Inc. - Organizational developments
      • Table Akorn Inc. - Segment focus
      • Table Akorn Inc. - Key offerings
      • Table Akorn Inc. - Key customers
    • Allergan Plc
      • Table Allergan Plc - Vendor overview
      • Table Allergan Plc - Product segments
      • Table Allergan Plc - Organizational developments
      • Table Allergan Plc - Segment focus
      • Table Allergan Plc - Key offerings
      • Table Allergan Plc - Key customers
    • Bausch Health Companies Inc.
      • Table Bausch Health Companies Inc. - Vendor overview
      • Table Bausch Health Companies Inc. - Business segments
      • Table Bausch Health Companies Inc. - Organizational developments
      • Table Bausch Health Companies Inc. - Geographic focus
      • Table Bausch Health Companies Inc. - Segment focus
      • Table Bausch Health Companies Inc. - Key offerings
      • Table Bausch Health Companies Inc. - Key customers
    • Bayer AG
      • Table Bayer AG - Vendor overview
      • Table Bayer AG - Business segments
      • Table Bayer AG - Organizational developments
      • Table Bayer AG - Geographic focus
      • Table Bayer AG - Segment focus
      • Table Bayer AG - Key offerings
      • Table Bayer AG - Key customers
    • Daiichi Sankyo Co. Ltd.
      • Table Daiichi Sankyo Co. Ltd. - Vendor overview
      • Table Daiichi Sankyo Co. Ltd. - Business segments
      • Table Daiichi Sankyo Co. Ltd. - Organizational developments
      • Table Daiichi Sankyo Co. Ltd. - Geographic focus
      • Table Daiichi Sankyo Co. Ltd. - Key offerings
      • Table Daiichi Sankyo Co. Ltd. - Key customers
    • GlaxoSmithKline Plc
      • Table GlaxoSmithKline Plc - Vendor overview
      • Table GlaxoSmithKline Plc - Business segments
      • Table GlaxoSmithKline Plc - Organizational developments
      • Table GlaxoSmithKline Plc - Geographic focus
      • Table GlaxoSmithKline Plc - Segment focus
      • Table GlaxoSmithKline Plc - Key offerings
      • Table GlaxoSmithKline Plc - Key customers
    • Novartis AG
      • Table Novartis AG - Vendor overview
      • Table Novartis AG - Business segments
      • Table Novartis AG - Organizational developments
      • Table Novartis AG - Geographic focus
      • Table Novartis AG - Segment focus
      • Table Novartis AG - Key offerings
      • Table Novartis AG - Key customers
    • Pfizer Inc.
      • Table Pfizer Inc. - Vendor overview
      • Table Pfizer Inc. - Business segments
      • Table Pfizer Inc. - Organizational developments
      • Table Pfizer Inc. - Geographic focus
      • Table Pfizer Inc. - Segment focus
      • Table Pfizer Inc. - Key offerings
      • Table Pfizer Inc. - Key customers
    • Sanofi
      • Table Sanofi - Vendor overview
      • Table Sanofi - Business segments
      • Table Sanofi - Organizational developments
      • Table Sanofi - Geographic focus
      • Table Sanofi - Segment focus
      • Table Sanofi - Key offerings
      • Table Sanofi - Key customers
    • Santen Pharmaceutical Co. Ltd.
      • Table Santen Pharmaceutical Co. Ltd. - Vendor overview
      • Table Santen Pharmaceutical Co. Ltd. - Business segments
      • Table Santen Pharmaceutical Co. Ltd. - Organizational developments
      • Table Santen Pharmaceutical Co. Ltd. - Geographic focus
      • Table Santen Pharmaceutical Co. Ltd. - Segment focus
      • Table Santen Pharmaceutical Co. Ltd. - Key offerings
      • Table Santen Pharmaceutical Co. Ltd. - Key customers
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
    • Definition of market positioning of vendors
      • Table Definition of market positioning of vendors
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook